{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:14Z","timestamp":1792686254029,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell lines are crucial to elucidate mechanisms of tumorigenesis and serve as tools for cancer treatment screenings. Therefore, careful validation of whether these models have conserved properties of in vivo tumors is highly important. Thyrocyte-derived tumors are very interesting for cancer biology studies because from one cell type, at least five histologically characterized different benign and malignant tumor types can arise. To investigate whether thyroid tumor\u2013derived cell lines are representative in vitro models, characteristics of eight of those cell lines were investigated with microarrays, differentiation markers, and karyotyping. Our results indicate that these cell lines derived from differentiated and undifferentiated tumor types have evolved in vitro into similar phenotypes with gene expression profiles the closest to in vivo undifferentiated tumors. Accordingly, the absence of expression of most thyrocyte-specific genes, the nonresponsiveness to thyrotropin, as well as their large number of chromosomal abnormalities, suggest that these cell lines have acquired characteristics of fully dedifferentiated cells. They represent the outcome of an adaptation and evolution in vitro, which questions the reliability of these cell lines as models for differentiated tumors. However, they may represent useful models for undifferentiated cancers, and by their comparison with differentiated cells, can help to define the genes involved in the differentiation\/dedifferentiation process. The use of any cell line as a model for a cancer therefore requires prior careful and thorough validation for the investigated property. [Cancer Res 2007;67(17):8113\u201320]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4026","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T14:53:07Z","timestamp":1189003987000},"page":"8113-8120","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Human Thyroid Tumor Cell Lines Derived from Different Tumor Types Present a Common Dedifferentiated Phenotype"],"prefix":"10.1158","volume":"67","author":[{"given":"Wilma C.G.","family":"van Staveren","sequence":"first","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Weiss","family":"Soli\u0301s","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"},{"name":"2Artificial Intelligence Laboratory (IRIDIA-CoDE);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Delys","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Duprez","sequence":"additional","affiliation":[{"name":"3Cytogenetics Laboratory, Medical Genetics Department, Erasme Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Andry","sequence":"additional","affiliation":[{"name":"4Department of Surgery, Jules Bordet Institute, Universite\u0301 Libre de Bruxelles, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Franc","sequence":"additional","affiliation":[{"name":"5Service d'Anatomie et de Cytologie Pathologiques, Ho\u0302pital A. Pare\u0301 (AP-HP), Universite\u0301 de Versailles, St. Quentin en Yvelines, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Thomas","sequence":"additional","affiliation":[{"name":"6South West Wales Cancer Institute\/Swansea Clinical School, Singleton Hospital, Swansea, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fre\u0301de\u0301rick","family":"Libert","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"Dumont","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Detours","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Maenhaut","sequence":"additional","affiliation":[{"name":"1Institute of Interdisciplinary Research (IRIBHM);"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,9,5]]},"reference":[{"key":"2022061623240305900_B1","doi-asserted-by":"crossref","unstructured":"Pacifico F, Mauro C, Barone C, et al. Oncogenic and anti-apoptotic activity of NF-\u03baB in human thyroid carcinomas. J Biol Chem\u20082004; 279: 54610\u20139.","DOI":"10.1074\/jbc.M403492200"},{"key":"2022061623240305900_B2","doi-asserted-by":"crossref","unstructured":"Schmutzler C, Cuong HV, Ruger B, Kohrle J. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. Eur J Endocrinol\u20082004; 150: 547\u201356.","DOI":"10.1530\/eje.0.1500547"},{"key":"2022061623240305900_B3","doi-asserted-by":"crossref","unstructured":"Venkataraman GM, Yatin M, Marcinek R, Ain KB. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: Relationship to human Na+\/I\u2212 symporter gene methylation status. J Clin Endocrinol Metab\u20081999; 84: 2449\u201357.","DOI":"10.1210\/jc.84.7.2449"},{"key":"2022061623240305900_B4","doi-asserted-by":"crossref","unstructured":"Weinstein JN, Myers TG, O'Connor PM, et al. An information-intensive approach to the molecular pharmacology of cancer. Science\u20081997; 275: 343\u20139.","DOI":"10.1126\/science.275.5298.343"},{"key":"2022061623240305900_B5","unstructured":"Ain KB, Taylor KD, Banks ER, Pettigrew AL. Characterization of an immortalized cell-line (KAK-1) from a benign human thyroid follicular adenoma. Thyroid\u20081992; 2: S49."},{"key":"2022061623240305900_B6","doi-asserted-by":"crossref","unstructured":"Goretzki PE, Frilling A, Simon D, Rastegar M, Ohmann C. Growth regulation of human thyrocytes by thyrotropin, cyclic adenosine monophosphate, epidermal growth factor and insulin-like growth factor. In: Goretzki PE, Ro\u0308her HD editors. Frontiers of hormone research. Basel: Karger; 1989. p. 56\u201380.","DOI":"10.1159\/000417502"},{"key":"2022061623240305900_B7","doi-asserted-by":"crossref","unstructured":"Estour B, Vanherle AJ, Juillard GJF, et al. Characterization of a human follicular thyroid-carcinoma cell-line (UCLA-RO 82 W-1). Virchows Arch B Cell Pathol\u20081989; 57: 167\u201374.","DOI":"10.1007\/BF02899078"},{"key":"2022061623240305900_B8","doi-asserted-by":"crossref","unstructured":"Fabien N, Fusco A, Santoro M, et al. Description of a human papillary thyroid-carcinoma cell-line\u2014morphologic study and expression of tumoral markers. Cancer\u20081994; 73: 2206\u201312.","DOI":"10.1002\/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M"},{"key":"2022061623240305900_B9","doi-asserted-by":"crossref","unstructured":"Ain KB, Taylor KD, Tofiq S, Venkataraman G. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab\u20081997; 82: 1857\u201362.","DOI":"10.1210\/jc.82.6.1857"},{"key":"2022061623240305900_B10","doi-asserted-by":"crossref","unstructured":"Tanaka J, Ogura T, Sato H, Hatano M. Establishment and biological characterization of an in vitro human cytomegalovirus latency model. Virology\u20081987; 161: 62\u201372.","DOI":"10.1016\/0042-6822(87)90171-1"},{"key":"2022061623240305900_B11","doi-asserted-by":"crossref","unstructured":"Ito T, Seyama T, Hayashi Y, et al. Establishment of 2 human thyroid-carcinoma cell-lines (8305C, 8505C) bearing p53 gene-mutations. Int J Oncol\u20081994; 4: 583\u20136.","DOI":"10.3892\/ijo.4.3.583"},{"key":"2022061623240305900_B12","doi-asserted-by":"crossref","unstructured":"Ain KB, Taylor KD. Somatostatin analogs affect proliferation of human thyroid-carcinoma cell-lines in vitro. J Clin Endocrinol Metab\u20081994; 78: 1097\u2013102.","DOI":"10.1210\/jc.78.5.1097"},{"key":"2022061623240305900_B13","doi-asserted-by":"crossref","unstructured":"Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer\u20082006; 6: 292\u2013306.","DOI":"10.1038\/nrc1836"},{"key":"2022061623240305900_B14","doi-asserted-by":"crossref","unstructured":"Fryknas M, Wickenberg-Bolin U, Goransson H, et al. Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol\u20082006; 27: 211\u201320.","DOI":"10.1159\/000093056"},{"key":"2022061623240305900_B15","doi-asserted-by":"crossref","unstructured":"Aldred MA, Huang Y, Liyanarachchi S, et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol\u20082004; 22: 3531\u20139.","DOI":"10.1200\/JCO.2004.08.127"},{"key":"2022061623240305900_B16","doi-asserted-by":"crossref","unstructured":"van Staveren WCG, Weiss Soli\u0301s D, Delys L, et al. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. Proc Natl Acad Sci U S A\u20082006; 103: 413\u20138.","DOI":"10.1073\/pnas.0507354102"},{"key":"2022061623240305900_B17","doi-asserted-by":"crossref","unstructured":"Delys L, Detours V, Franc B, et al. Gene expression and biological phenotype of papillary thyroid carcinomas. Oncogene 2007; Jul 9: [Epub ahead of print].","DOI":"10.1038\/sj.onc.1210588"},{"key":"2022061623240305900_B18","doi-asserted-by":"crossref","unstructured":"Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol\u20082004; 5: R80.","DOI":"10.1186\/gb-2004-5-10-r80"},{"key":"2022061623240305900_B19","doi-asserted-by":"crossref","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A\u20082001; 98: 5116\u201321.","DOI":"10.1073\/pnas.091062498"},{"key":"2022061623240305900_B20","doi-asserted-by":"crossref","unstructured":"Rocha AS, De Wever O, Moreira S, et al. Mutated E-cadherin: genomic and functional characterization in thyroid cells from the KAT family. Thyroid\u20082004; 14: 902\u20139.","DOI":"10.1089\/thy.2004.14.902"},{"key":"2022061623240305900_B21","doi-asserted-by":"crossref","unstructured":"Brabant G, Maenhaut C, Kohrle J, et al. Human thyrotropin receptor gene\u2014expression in thyroid-tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol\u20081991; 82: R7\u201312.","DOI":"10.1016\/0303-7207(91)90018-N"},{"key":"2022061623240305900_B22","doi-asserted-by":"crossref","unstructured":"Ros P, Rossi DL, Acebron A, Santisteban P. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie\u20081999; 81: 389\u201396.","DOI":"10.1016\/S0300-9084(99)80086-8"},{"key":"2022061623240305900_B23","doi-asserted-by":"crossref","unstructured":"Chen ST, Shieh HY, Lin JD, Chang KSS, Lin KH. Overexpression of thyroid hormone receptor \u03b21 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line. J Endocrinol\u20082000; 165: 379\u201389.","DOI":"10.1677\/joe.0.1650379"},{"key":"2022061623240305900_B24","unstructured":"Xing MZ, Usadel H, Cohen Y, et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res\u20082003; 63: 2316\u201321."},{"key":"2022061623240305900_B25","doi-asserted-by":"crossref","unstructured":"Ward LS, Brenta G, Medvedovic M, Fagin JA. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab\u20081998; 83: 525\u201330.","DOI":"10.1210\/jc.83.2.525"},{"key":"2022061623240305900_B26","doi-asserted-by":"crossref","unstructured":"Corso C, Ulucan H, Parry EM, Parry JM. Comparative analysis of two thyroid tumor cell lines by fluorescence in situ hybridization and comparative genomic hybridization. Cancer Genet Cytogenet\u20082002; 137: 108\u201318.","DOI":"10.1016\/S0165-4608(02)00562-9"},{"key":"2022061623240305900_B27","doi-asserted-by":"crossref","unstructured":"Dettori T, Frau DV, Garcia JL, et al. Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line. Cancer Genet Cytogenet\u20082004; 151: 171\u20137.","DOI":"10.1016\/j.cancergencyto.2003.09.023"},{"key":"2022061623240305900_B28","doi-asserted-by":"crossref","unstructured":"Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet\u20082000; 24: 227\u201335.","DOI":"10.1038\/73432"},{"key":"2022061623240305900_B29","doi-asserted-by":"crossref","unstructured":"Lacroix L, Nocera M, Mian C, et al. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid\u20082001; 11: 1017\u201323.","DOI":"10.1089\/105072501753271699"},{"key":"2022061623240305900_B30","doi-asserted-by":"crossref","unstructured":"Lotem M, Yehuda-Gafni O, Butnaryu E, et al. Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell cultures. Cancer Genet Cytogenet\u20082003; 142: 87\u201391.","DOI":"10.1016\/S0165-4608(02)00798-7"},{"key":"2022061623240305900_B31","doi-asserted-by":"crossref","unstructured":"Ooi GT, Tawadros N, Escalona RM. Pituitary cell lines and their endocrine applications. Mol Cell Endocrinol\u20082004; 228: 1\u201321.","DOI":"10.1016\/j.mce.2004.07.018"},{"key":"2022061623240305900_B32","unstructured":"Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene\u20081996; 13: 687\u201393."},{"key":"2022061623240305900_B33","doi-asserted-by":"crossref","unstructured":"Wynford-Thomas D. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res\u20081997; 47: 145\u201357.","DOI":"10.1159\/000185458"},{"key":"2022061623240305900_B34","doi-asserted-by":"crossref","unstructured":"Jossart GH, Epstein HD, Shaver JK, et al. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. J Clin Endocrinol Metab\u20081996; 81: 3498\u2013504.","DOI":"10.1210\/jc.81.10.3498"},{"key":"2022061623240305900_B35","doi-asserted-by":"crossref","unstructured":"La Perle KM, Jhiang SM, Capen CC. Loss of p53 promotes anaplasia and local invasion in ret\/PTC1-induced thyroid carcinomas. Am J Pathol\u20082000; 157: 671\u20137.","DOI":"10.1016\/S0002-9440(10)64577-4"},{"key":"2022061623240305900_B36","doi-asserted-by":"crossref","unstructured":"Castedo M, Perfettini JL, Roumier T, et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene\u20082004; 23: 4362\u201370.","DOI":"10.1038\/sj.onc.1207572"},{"key":"2022061623240305900_B37","doi-asserted-by":"crossref","unstructured":"Chun YS, Saji M, Zeiger MA. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines. Surgery\u20081998; 124: 1100\u20135.","DOI":"10.1067\/msy.1998.92008"},{"key":"2022061623240305900_B38","doi-asserted-by":"crossref","unstructured":"De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev\u20082004; 25: 722\u201346.","DOI":"10.1210\/er.2003-0028"},{"key":"2022061623240305900_B39","doi-asserted-by":"crossref","unstructured":"Hawthorn L, Stein L, Varma R, et al. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck\u20082004; 26: 1069\u201383.","DOI":"10.1002\/hed.20099"},{"key":"2022061623240305900_B40","doi-asserted-by":"crossref","unstructured":"Arnaldi LAT, Borra RC, Maciel RMB, Cerutti JM. Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors. Thyroid\u20082005; 15: 210\u201321.","DOI":"10.1089\/thy.2005.15.210"},{"key":"2022061623240305900_B41","doi-asserted-by":"crossref","unstructured":"Schagdarsurengin U, Gimm O, Dralle H, Hoang-Vu C, Dammann R. CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. Thyroid\u20082006; 16: 633\u201342.","DOI":"10.1089\/thy.2006.16.633"},{"key":"2022061623240305900_B42","doi-asserted-by":"crossref","unstructured":"Soares P, Trovisco V, Rocha AS, et al. BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene\u20082003; 22: 4578\u201380.","DOI":"10.1038\/sj.onc.1206706"},{"key":"2022061623240305900_B43","doi-asserted-by":"crossref","unstructured":"Ishizaka Y, Ushijima T, Sugimura T, Nagao M. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun\u20081990; 168: 402\u20138.","DOI":"10.1016\/0006-291X(90)92335-W"},{"key":"2022061623240305900_B44","doi-asserted-by":"crossref","unstructured":"Virtanen C, Ishikawa Y, Honjoh D, et al. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci U S A\u20082002; 99: 12357\u201362.","DOI":"10.1073\/pnas.192240599"},{"key":"2022061623240305900_B45","doi-asserted-by":"crossref","unstructured":"Mehrian SR, Reichardt JK, Ya-Hsuan H, et al. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines. Brain Res Mol Brain Res\u20082005; 136: 99\u2013103.","DOI":"10.1016\/j.molbrainres.2005.01.017"},{"key":"2022061623240305900_B46","unstructured":"Pedersen N, Mortensen S, Sorensen SB, et al. Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res\u20082003; 63: 1943\u201353."},{"key":"2022061623240305900_B47","doi-asserted-by":"crossref","unstructured":"Perou CM, Jeffrey SS, van de RM, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A\u20081999; 96: 9212\u20137.","DOI":"10.1073\/pnas.96.16.9212"},{"key":"2022061623240305900_B48","doi-asserted-by":"crossref","unstructured":"Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers\u20082001; 17: 99\u2013109.","DOI":"10.1155\/2001\/850531"},{"key":"2022061623240305900_B49","doi-asserted-by":"crossref","unstructured":"Sandberg R, Ernberg I. The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles. Genome Biol\u20082005; 6: R65.","DOI":"10.1186\/gb-2005-6-8-r65"},{"key":"2022061623240305900_B50","doi-asserted-by":"crossref","unstructured":"Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell\u20082006; 9: 391\u2013403.","DOI":"10.1016\/j.ccr.2006.03.030"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/17\/8113\/2572758\/8113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/17\/8113\/2572758\/8113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:19:48Z","timestamp":1737389988000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/17\/8113\/533433\/Human-Thyroid-Tumor-Cell-Lines-Derived-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":50,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2007,9,5]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4026","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22367909.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367921.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367912.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367915.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367918.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367906","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367918","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367909","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367924.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367921","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367912","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367903","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367906.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367915","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367903.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495737.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495737","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}